The global Proteomics market size reached a valuation of US$ 30,825.04 Million in 2022. Increasing adoption of precision medicine and sophisticated diagnostics in specific target disease treatment, as well as the increased concentration of target diseases, are significant drivers of growth prospects.
Demand for Proteomics is projected to grow at a robust CAGR of 13.5% between 2022 and 2032, totaling around US$ 109,485.7 Million by the end of 2032.
| Data Points | Key Statistics |
|---|---|
| Proteomics Market Size (2022) | US$ 30,825.04 Million |
| Proteomics Market Revenue Forecast (2032) | US$ 109,485.7 Million |
| Proteomics Market Growth Rate (2022 to 2032) | 13.5% CAGR |
| North America Market Share | 35% |
A proteome is the complete set of proteins produced by a system or organism. It can transform based on the time, specifications, and stresses that an organism is confined to. Proteomic research refers to the systematic study of proteins on a large scale. Because proteins are the fundamental units of cells, proteomic research aims to answer all questionnaires about them.
Breakthroughs in mass spectrometry and protein and DNA sequence databases can assist proteomics research. Proteomics necessitates a wide range of instruments, machinery, reagents, media, and software for protein identification, quantitative determination, and recognition of protein interactions.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Continued growth for personalized medicine, technical progress, and innovation, as well as enhanced funding opportunities from both the public and private sectors for proteomics, are among the most crucial driving factors in the proteomics industry.
Because the pharmaceutical and biopharmaceutical markets are expanding rapidly, the clamor for proteomics has accelerated. Furthermore, the global industry is anticipated to expand rapidly in the coming decades as an outcome of technological advancements, extensive research funding, escalating healthcare costs, rising numbers for tailored medication, and price inflation of genetic illnesses.
Another factor expected to propel overall growth is the higher incidence of chronic diseases such as cancer, Cardiovascular Diseases (CVDs), respiratory diseases, CKD, and others. As per Globocan, there were 19.3 million new cancer patients and 10 million cancer-related deaths globally in December 2020. Similarly, CVDs are among the world's most prevalent causes of death.
Despite its numerous benefits and wonderful features, proteomics also has a few drawbacks. The high price of medicines and equipment, as well as a scarcity of research scholars, are stifling the proteomics market.
Principal Consultant
North America dominated the market in 2021, with a 46% revenue share. This is due to higher investments in the innovation of structure-based drug design, advancement in omics research, the requirement for high-quality research tools for data replicability, and a focus on the creation of tailored treatments. Agreements and collaborations among major corporations in this region are also assisting in the advancement of this market.
For example, Thermo Fisher Scientific Inc. and Symphogen collaborated to create validated platform mechanisms for the streamlined classification and monitoring, and management of complex protein therapeutics. North America is accounting for a market share of 35% of the global Proteomics market.
Rapid growth for personalized medicines, as well as increased research and development in proteomics, are acting as a catalyst in the market. The clamor for spectroscopy proteomics is likely to increase as the prevalence of breast cancer rises. This is expected to aid the advancement of the Asia-Pacific proteomics market.
These are the primary drivers that will continue to fuel the biopharmaceutical firm's endeavor of blockbuster drugs, as well as the latest technological advancements in gene and protein research.
Because it is challenging for organizations to find all of the required expertise to encompass all of the activities associated with proteomics, alliances seem to become progressively crucial in this field. Many manufacturers, for example, are cooperating with mass spectrometry, and both automakers and end-user labs are partnering with protein chip-related companies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global market for personalized medicine in Europe, as well as the existence of major market players such as Merck KGaA, are expected to propel growth in the region. Additionally, proactive support from European local governments and approaches by research organizations to develop proteomics technologies such as chemo proteomics and spectrometry is expected to fuel market growth.
Rising research grants and active projects by European research institutes and big players, especially in the United Kingdom, drive demand in the researched market.
For example, in December 2020, the United Kingdom Biobank collaborated on the Pharma Proteomics Project with the Biopharma Consortium, which included ten biopharmaceutical enterprises. Europe is accounting for a market share of 23.1% of the global proteomics market.
In 2021, the spectroscopy segment had the largest share of revenue at more than 46.9%. During the projected timeline, it is presumed to accelerate at the fastest rate. The pervasive use of spectroscopy-based technological innovations in many application domains, such as drug development procedures, proteomics, metabolomics, forensic investigation, and pharmacological analysis, is one of the major drivers of segment growth.
In 2021, the clinical diagnostics segment led the industry with a market share of more than 52%. This is due to the extensive use of protein analysis by clinical researchers to identify disease biomarkers for early recognition and specific risk factors.
This is anticipated to open up new avenues for ailment early detection and prevention. It is possible to discover potential biomarkers and nutrient expression patterns that can be utilized to classify and anticipate tumors, as well as ascertain their prognosis, using proteomics-based medical assessment, which contributes significantly to the segment's development.
How key Players are opening Frontiers for Future Growth?
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a larger customer base.
For instance,
Who are the Leading Players in Proteomics Market?
Some of the leading Proteomics manufacturers include Agilent Technologies, Thermo Fisher Scientific Inc., Danaher Corporation, Genzyme Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Affymetrix Inc, Seer, SCIEX, and SomaLogic.
These key proteomics providers are adopting various strategies such as new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc. to increase their sales and gain a competitive edge in the global proteomics market.
For instance
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 13.5% from 2022 to 2032 |
| Market Value in 2022 | US$ 30,825.04 Million |
| Market Value in 2032 | US$ 109,485.7 Million |
| Base Year for Estimates | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled | Agilent Technologies, Thermo Fisher Scientific Inc., Danaher Corporation, Genzyme Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Affymetrix Inc., Seer, SCIEX, SomaLogic. |
| Report Customization & Pricing | Available upon Request |
The global Proteomics market reached US$ 30825.04 Million in 2022.
As per FMI, the Proteomics industry is expected to grow at a CAGR of 13.5% throughout the forecast period (2022 to 2032).
The global sales of Proteomics are anticipated to total a valuation of US$ 109485.7 Million by 2032.
Some of the leading manufacturers include Agilent Technologies, Thermo Fisher Scientific Inc., Danaher Corporation, Genzyme Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Affymetrix Inc, Seer, SCIEX, and SomaLogic.
North America will continue to remain the most lucrative market for proteomics, accounting for a share of 35% of the global Proteomics market in 2022.
1. Executive Summary | Proteomics Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2016 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Equipment
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Equipment, 2016 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Equipment, 2022 to 2032
5.3.1. Chromatography
5.3.2. Mass Spectroscopy
5.3.3. Protein Microarray
5.3.4. X-ray Crystallography
5.3.5. Protein fractionation
5.3.6. Others
5.4. Y-o-Y Growth Trend Analysis By Equipment, 2016 to 2021
5.5. Absolute $ Opportunity Analysis By Equipment, 2022 to 2032
6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Services
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Services, 2016 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Services, 2022 to 2032
6.3.1. Laboratory Service
6.3.2. Data Analysis and Services
6.4. Y-o-Y Growth Trend Analysis By Services, 2016 to 2021
6.5. Absolute $ Opportunity Analysis By Services, 2022 to 2032
7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2016 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032
7.3.1. Drug discovery
7.3.2. Clinical Diagnosis
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By Application, 2016 to 2021
7.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
8. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2016 to 2021
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Equipment
9.2.3. By Services
9.2.4. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Equipment
9.3.3. By Services
9.3.4. By Application
9.4. Key Takeaways
10. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Equipment
10.2.3. By Services
10.2.4. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Equipment
10.3.3. By Services
10.3.4. By Application
10.4. Key Takeaways
11. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Equipment
11.2.3. By Services
11.2.4. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Equipment
11.3.3. By Services
11.3.4. By Application
11.4. Key Takeaways
12. South Asia Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Equipment
12.2.3. By Services
12.2.4. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Equipment
12.3.3. By Services
12.3.4. By Application
12.4. Key Takeaways
13. East Asia Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Equipment
13.2.3. By Services
13.2.4. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Equipment
13.3.3. By Services
13.3.4. By Application
13.4. Key Takeaways
14. Oceania Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Equipment
14.2.3. By Services
14.2.4. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Equipment
14.3.3. By Services
14.3.4. By Application
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of Middle East and Africa
15.2.2. By Equipment
15.2.3. By Services
15.2.4. By Application
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Equipment
15.3.3. By Services
15.3.4. By Application
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Equipment
16.1.2.2. By Services
16.1.2.3. By Application
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Equipment
16.2.2.2. By Services
16.2.2.3. By Application
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Equipment
16.3.2.2. By Services
16.3.2.3. By Application
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Equipment
16.4.2.2. By Services
16.4.2.3. By Application
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Equipment
16.5.2.2. By Services
16.5.2.3. By Application
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2021
16.6.2.1. By Equipment
16.6.2.2. By Services
16.6.2.3. By Application
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2021
16.7.2.1. By Equipment
16.7.2.2. By Services
16.7.2.3. By Application
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2021
16.8.2.1. By Equipment
16.8.2.2. By Services
16.8.2.3. By Application
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2021
16.9.2.1. By Equipment
16.9.2.2. By Services
16.9.2.3. By Application
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2021
16.10.2.1. By Equipment
16.10.2.2. By Services
16.10.2.3. By Application
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2021
16.11.2.1. By Equipment
16.11.2.2. By Services
16.11.2.3. By Application
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2021
16.12.2.1. By Equipment
16.12.2.2. By Services
16.12.2.3. By Application
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2021
16.13.2.1. By Equipment
16.13.2.2. By Services
16.13.2.3. By Application
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2021
16.14.2.1. By Equipment
16.14.2.2. By Services
16.14.2.3. By Application
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2021
16.15.2.1. By Equipment
16.15.2.2. By Services
16.15.2.3. By Application
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2021
16.16.2.1. By Equipment
16.16.2.2. By Services
16.16.2.3. By Application
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2021
16.17.2.1. By Equipment
16.17.2.2. By Services
16.17.2.3. By Application
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2021
16.18.2.1. By Equipment
16.18.2.2. By Services
16.18.2.3. By Application
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2021
16.19.2.1. By Equipment
16.19.2.2. By Services
16.19.2.3. By Application
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2021
16.20.2.1. By Equipment
16.20.2.2. By Services
16.20.2.3. By Application
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2021
16.21.2.1. By Equipment
16.21.2.2. By Services
16.21.2.3. By Application
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Equipment
17.3.3. By Services
17.3.4. By Application
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Agilent Technologies
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Thermo Fisher Scientific Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Danaher Corporation
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Genzyme Corporation
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. GE Healthcare
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Bio-Rad Laboratories, Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Affymetrix Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Bruker Corporation
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Horiba, Ltd.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Waters Corporation
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Proteomics Market
